Yuekang Pharmaceutical (688658.SH): Using Idle Self-Owned Funds Not Exceeding 1.5 Billion Yuan for Cash Management

NightAirdropper · 2026-03-20T20:17:49+00:00

Yueykang Pharmaceutical held a board meeting on March 20, approving the use of up to 1.5 billion yuan of idle proprietary funds for cash management, investing in medium to low-risk wealth management products with a maturity period not exceeding 12 months, to ensure fund safety and normal business operations.

NightAirdropper

2026-03-20 20:17:49

Abstract generation in progress

Gelonghui, March 20 — Yuekang Pharmaceutical (688658.SH) announced that on March 20, 2026, the company’s third board of directors held its fourth meeting and approved the proposal regarding the use of idle funds for cash management. The company (including subsidiaries) agreed to use up to RMB 1.5 billion of idle funds for cash management, ensuring that the safety of the company’s funds and normal business operations are not affected. The funds will be used to purchase high-security, highly liquid, and low- to medium-risk financial products (including but not limited to negotiated deposits, notice deposits, fixed deposits, large-denomination certificates of deposit, structured deposits, and R1, R2 type financial products). The usage period will not exceed 12 months from the date of board approval, and within the specified limit and period, the funds can be rolled over.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.